La terapia enzimatica sostitutiva nella malattia di Fabry
Anderson-Fabry disease (FD) is a X-linked lysosomal storage disorder, which involves glycosphingolipids metabolism. Specific treatment for FD has been available in the last two decades, after the development and commercialization of recombinant human alfa-galactosidase A. Since then enzyme replaceme...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AboutScience Srl
2019-09-01
|
| シリーズ: | Giornale di Clinica Nefrologia e Dialisi |
| オンライン･アクセス: | https://journals.aboutscience.eu/index.php/gcnd/article/view/528 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|